[The industry recommends increased use. Biosimilars are like generics, but still not].
Richard
R
Bergström
Kenneth
K
Nyblom
D001688:Biological Products / Q000191:economics; D017046:Cost Savings; D016527:Drug Costs; D004345:Drug Industry; D016568:Drugs, Generic / Q000191:economics; D006801:Humans; D013810:Therapeutic Equivalency
D001688:Biological Products; D016568:Drugs, Generic